The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
2SEVENTY BIO INC COMMON STOCK 901384107   13,201 1,408,901 SH   SOLE   1,408,901 0 0
ACADIA PHARMACEUTICALS INC COM 004225108   11,166 701,402 SH   SOLE   701,402 0 0
AEGLEA BIOTHERAPEUTICS INC COM 00773J103   2,406 5,347,689 SH   SOLE   5,347,689 0 0
ANNEXON INC COM 03589W102   25,264 4,886,616 SH   SOLE   4,886,616 0 0
APTINYX INC COM 03836N103   2,537 8,891,758 SH   SOLE   8,891,758 0 0
ARCUTIS BIOTHERAPEUTICS INC COM 03969K108   44,400 3,000,000 SH   SOLE   3,000,000 0 0
ATEA PHARMACEUTICALS INC COM 04683R106   11,956 2,485,638 SH   SOLE   2,485,638 0 0
C4 THERAPEUTICS INC COM STK 12529R107   9,689 1,642,210 SH   SOLE   1,642,210 0 0
CARA THERAPEUTICS INC COM 140755109   28,955 2,696,030 SH   SOLE   2,696,030 0 0
CRINETICS PHARMACEUTICALS IN COM 22663K107   42,192 2,305,558 SH   SOLE   2,305,558 0 0
CTI BIOPHARMA CORP COM 12648L601   22,702 3,777,308 SH   SOLE   3,777,308 0 0
DYNAVAX TECHNOLOGIES CORP COM NEW 268158201   41,656 3,915,000 SH   SOLE   3,915,000 0 0
EQRX INC COM 26886C107   24,609 10,003,573 SH   SOLE   10,003,573 0 0
INVIVYD INC COM 00534A102   2,906 1,937,207 SH   SOLE   1,937,207 0 0
MARINUS PHARMACEUTICALS INC COM NEW 56854Q200   5,696 1,431,058 SH   SOLE   1,431,058 0 0
MERSANA THERAPEUTICS INC COM 59045L106   50,769 8,663,673 SH   SOLE   8,663,673 0 0
NATERA INC COM 632307104   56,238 1,400,000 SH   SOLE   1,400,000 0 0
NAUTILUS BIOTECHNOLOGY INC COM 63909J108   3,600 2,000,000 SH   SOLE   2,000,000 0 0
NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES N62509109   90,470 8,300,000 SH   SOLE   8,300,000 0 0
NEWAMSTERDAM PHARMA COMPANY *W EXP 11/22/202 N62509117   86 100,000 SH   SOLE   100,000 0 0
NURIX THERAPEUTICS INC COM 67080M103   20,015 1,822,883 SH   SOLE   1,822,883 0 0
NUVALENT INC COM 670703107   106,531 3,577,267 SH   SOLE   3,577,267 0 0
PHARVARIS N V COM N69605108   35,782 3,180,601 SH   SOLE   3,180,601 0 0
PROTAGONIST THERAPEUTICS INC COM 74366E102   25,796 2,364,410 SH   SOLE   2,364,410 0 0
RAPID MICRO BIOSYSTEMS INC CLASS A COM 75340L104   9,531 8,434,560 SH   SOLE   8,434,560 0 0
SAVARA INC COM 805111101   18,015 11,622,598 SH   SOLE   11,622,598 0 0
SOLID BIOSCIENCES INC COM NEW 83422E204   16,842 3,130,422 SH   SOLE   3,130,422 0 0
SPRINGWORKS THERAPEUTICS INC COM 85205L107   125,662 4,831,307 SH   SOLE   4,831,307 0 0
SYROS PHARMACEUTICALS INC COM NEW 87184Q206   7,628 2,124,694 SH   SOLE   2,124,694 0 0
TANGO THERAPEUTICS INC COM 87583X109   13,933 1,921,790 SH   SOLE   1,921,790 0 0
THIRD HARMONIC BIO INC COM 88427A107   4,952 1,151,657 SH   SOLE   1,151,657 0 0
X4 PHARMACEUTICALS INC COM 98420X103   12,117 12,202,510 SH   SOLE   12,202,510 0 0
XILIO THERAPEUTICS INC COM 98422T100   7,547 2,805,413 SH   SOLE   2,805,413 0 0